This study tests whether adding the experimental drug ivaltinostat to standard chemotherapy (capecitabine) can help keep metastatic pancreatic cancer from worsening. About 70 adults whose cancer did not progress on initial treatment will receive either the combination or capecita…
Phase: PHASE1, PHASE2 • Sponsor: CG Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC